Replies to post #8116 on Momenta Pharmaceuticals, Inc. (MNTA)

[GrthzGd]

Ah, so that is why DNDN was up 40% today :- )

Most, but IMO not all, of the increase was because the DNDN's fourth quarter revenue from its prostate cancer vaccine Provenge increased more than three times. Congratulations if you were in that stock!